Global HIV Antiretroviral Drug Production, Demand and Key Producers, 2022-2028
This report studies the global HIV Antiretroviral Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for HIV Antiretroviral Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of HIV Antiretroviral Drug that contribute to its increasing demand across many markets.
The global HIV Antiretroviral Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global HIV Antiretroviral Drug total market, 2017-2028, (USD Million)
Global HIV Antiretroviral Drug total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: HIV Antiretroviral Drug total market, key domestic companies and share, (USD Million)
Global HIV Antiretroviral Drug revenue by player and market share 2017-2022, (USD Million)
Global HIV Antiretroviral Drug total market by Type, CAGR, 2017-2028, (USD Million)
Global HIV Antiretroviral Drug total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global HIV Antiretroviral Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ViiV Healthcare(GlaxoSmithKline), Gilead Sciences, AbbVie Inc., Merck & Co, GSK, Bristol-Myers Squibb Company, Theratechnologies Inc., Roche Holding AG and Teva Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HIV Antiretroviral Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global HIV Antiretroviral Drug Market, By Region:
1. How big is the global HIV Antiretroviral Drug market?
2. What is the demand of the global HIV Antiretroviral Drug market?
3. What is the year over year growth of the global HIV Antiretroviral Drug market?
4. What is the total value of the global HIV Antiretroviral Drug market?
5. Who are the major players in the global HIV Antiretroviral Drug market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for HIV Antiretroviral Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of HIV Antiretroviral Drug that contribute to its increasing demand across many markets.
The global HIV Antiretroviral Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global HIV Antiretroviral Drug total market, 2017-2028, (USD Million)
Global HIV Antiretroviral Drug total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: HIV Antiretroviral Drug total market, key domestic companies and share, (USD Million)
Global HIV Antiretroviral Drug revenue by player and market share 2017-2022, (USD Million)
Global HIV Antiretroviral Drug total market by Type, CAGR, 2017-2028, (USD Million)
Global HIV Antiretroviral Drug total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global HIV Antiretroviral Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ViiV Healthcare(GlaxoSmithKline), Gilead Sciences, AbbVie Inc., Merck & Co, GSK, Bristol-Myers Squibb Company, Theratechnologies Inc., Roche Holding AG and Teva Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HIV Antiretroviral Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global HIV Antiretroviral Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Nucleoside Reverse Transcriptase Inhibitors
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Fusion Inhibitors
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- ViiV Healthcare(GlaxoSmithKline)
- Gilead Sciences
- AbbVie Inc.
- Merck & Co
- GSK
- Bristol-Myers Squibb Company
- Theratechnologies Inc.
- Roche Holding AG
- Teva Pharmaceuticals
- Pfizer
- Frontier Biotechnologies
- Shionogi
- Julphar Bangladesh
- Mylan Pharmaceuticals Inc.
- Genentech, Inc.
- Boehringer Ingelheim
- Cipla
- MSD
- Abbott
- Johnson & Johnson
- Biocon Limited
- Affine Formulations Limited
- IPCA Laboratories
- Natco Pharma
- Beacon Pharmaceuticals
1. How big is the global HIV Antiretroviral Drug market?
2. What is the demand of the global HIV Antiretroviral Drug market?
3. What is the year over year growth of the global HIV Antiretroviral Drug market?
4. What is the total value of the global HIV Antiretroviral Drug market?
5. Who are the major players in the global HIV Antiretroviral Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 HIV Antiretroviral Drug Introduction
1.2 World HIV Antiretroviral Drug Market Size & Forecast (2017 & 2021 & 2028)
1.3 World HIV Antiretroviral Drug Total Market by Region
1.3.1 World HIV Antiretroviral Drug Market Size by Region (2017-2028)
1.3.2 United States HIV Antiretroviral Drug Market Size (2017-2028)
1.3.3 China HIV Antiretroviral Drug Market Size (2017-2028)
1.3.4 Europe HIV Antiretroviral Drug Market Size (2017-2028)
1.3.5 Japan HIV Antiretroviral Drug Market Size (2017-2028)
1.3.6 South Korea HIV Antiretroviral Drug Market Size (2017-2028)
1.3.7 ASEAN HIV Antiretroviral Drug Market Size (2017-2028)
1.3.8 India HIV Antiretroviral Drug Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 HIV Antiretroviral Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 HIV Antiretroviral Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD HIV ANTIRETROVIRAL DRUG COMPANIES COMPETITIVE ANALYSIS
2.1 World HIV Antiretroviral Drug Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global HIV Antiretroviral Drug Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for HIV Antiretroviral Drug in 2021
2.2.3 Global Concentration Ratios (CR8) for HIV Antiretroviral Drug in 2021
2.3 HIV Antiretroviral Drug Company Evaluation Quadrant
2.4 HIV Antiretroviral Drug Market: Overall Company Footprint Analysis
2.4.1 HIV Antiretroviral Drug Market: Region Footprint
2.4.2 HIV Antiretroviral Drug Market: Company Product Type Footprint
2.4.3 HIV Antiretroviral Drug Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: HIV Antiretroviral Drug Market Comparison
3.1.1 United States VS China: HIV Antiretroviral Drug Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: HIV Antiretroviral Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States HIV Antiretroviral Drug Major Players and Market Share, 2017-2022
3.2.1 Major Players of HIV Antiretroviral Drug in United States, Headquarters (States, Country)
3.2.2 United States HIV Antiretroviral Drug Revenue by Domestic Player, (2017-2022)
3.3 China HIV Antiretroviral Drug Major Players and Market Share, 2017-2022
3.3.1 Major Players of HIV Antiretroviral Drug in China, Headquarters (Province, Country)
3.3.2 China HIV Antiretroviral Drug Revenue by Domestic Player, (2017-2022)
3.4 Rest of World HIV Antiretroviral Drug Major Players and Market Share, 2017-2022
3.4.1 Major Players of HIV Antiretroviral Drug in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World HIV Antiretroviral Drug Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World HIV Antiretroviral Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Nucleoside Reverse Transcriptase Inhibitors
4.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors
4.2.3 Protease Inhibitors
4.2.4 Fusion Inhibitors
4.2.5 Others
4.3 Market Segment by Type
4.3.1 World HIV Antiretroviral Drug Market Size by Type (2017-2022)
4.3.2 World HIV Antiretroviral Drug Market Size by Type (2023-2028)
4.3.3 World HIV Antiretroviral Drug Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World HIV Antiretroviral Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospital Pharmacies
5.2.2 Retail Pharmacies
5.2.3 Online Pharmacies
5.3 Market Segment by Application
5.3.1 World HIV Antiretroviral Drug Market Size by Application (2017-2022)
5.3.2 World HIV Antiretroviral Drug Market Size by Application (2023-2028)
5.3.3 World HIV Antiretroviral Drug Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 ViiV Healthcare(GlaxoSmithKline)
6.1.1 ViiV Healthcare(GlaxoSmithKline) Details
6.1.2 ViiV Healthcare(GlaxoSmithKline) Major Business
6.1.3 ViiV Healthcare(GlaxoSmithKline) HIV Antiretroviral Drug Product and Services
6.1.4 ViiV Healthcare(GlaxoSmithKline) HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 ViiV Healthcare(GlaxoSmithKline) Recent Developments/Updates
6.1.6 ViiV Healthcare(GlaxoSmithKline) Competitive Strengths & Weaknesses
6.2 Gilead Sciences
6.2.1 Gilead Sciences Details
6.2.2 Gilead Sciences Major Business
6.2.3 Gilead Sciences HIV Antiretroviral Drug Product and Services
6.2.4 Gilead Sciences HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Gilead Sciences Recent Developments/Updates
6.2.6 Gilead Sciences Competitive Strengths & Weaknesses
6.3 AbbVie Inc.
6.3.1 AbbVie Inc. Details
6.3.2 AbbVie Inc. Major Business
6.3.3 AbbVie Inc. HIV Antiretroviral Drug Product and Services
6.3.4 AbbVie Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 AbbVie Inc. Recent Developments/Updates
6.3.6 AbbVie Inc. Competitive Strengths & Weaknesses
6.4 Merck & Co
6.4.1 Merck & Co Details
6.4.2 Merck & Co Major Business
6.4.3 Merck & Co HIV Antiretroviral Drug Product and Services
6.4.4 Merck & Co HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Merck & Co Recent Developments/Updates
6.4.6 Merck & Co Competitive Strengths & Weaknesses
6.5 GSK
6.5.1 GSK Details
6.5.2 GSK Major Business
6.5.3 GSK HIV Antiretroviral Drug Product and Services
6.5.4 GSK HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 GSK Recent Developments/Updates
6.5.6 GSK Competitive Strengths & Weaknesses
6.6 Bristol-Myers Squibb Company
6.6.1 Bristol-Myers Squibb Company Details
6.6.2 Bristol-Myers Squibb Company Major Business
6.6.3 Bristol-Myers Squibb Company HIV Antiretroviral Drug Product and Services
6.6.4 Bristol-Myers Squibb Company HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.6.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
6.7 Theratechnologies Inc.
6.7.1 Theratechnologies Inc. Details
6.7.2 Theratechnologies Inc. Major Business
6.7.3 Theratechnologies Inc. HIV Antiretroviral Drug Product and Services
6.7.4 Theratechnologies Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Theratechnologies Inc. Recent Developments/Updates
6.7.6 Theratechnologies Inc. Competitive Strengths & Weaknesses
6.8 Roche Holding AG
6.8.1 Roche Holding AG Details
6.8.2 Roche Holding AG Major Business
6.8.3 Roche Holding AG HIV Antiretroviral Drug Product and Services
6.8.4 Roche Holding AG HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Roche Holding AG Recent Developments/Updates
6.8.6 Roche Holding AG Competitive Strengths & Weaknesses
6.9 Teva Pharmaceuticals
6.9.1 Teva Pharmaceuticals Details
6.9.2 Teva Pharmaceuticals Major Business
6.9.3 Teva Pharmaceuticals HIV Antiretroviral Drug Product and Services
6.9.4 Teva Pharmaceuticals HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Teva Pharmaceuticals Recent Developments/Updates
6.9.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
6.10 Pfizer
6.10.1 Pfizer Details
6.10.2 Pfizer Major Business
6.10.3 Pfizer HIV Antiretroviral Drug Product and Services
6.10.4 Pfizer HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Pfizer Recent Developments/Updates
6.10.6 Pfizer Competitive Strengths & Weaknesses
6.11 Frontier Biotechnologies
6.11.1 Frontier Biotechnologies Details
6.11.2 Frontier Biotechnologies Major Business
6.11.3 Frontier Biotechnologies HIV Antiretroviral Drug Product and Services
6.11.4 Frontier Biotechnologies HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Frontier Biotechnologies Recent Developments/Updates
6.11.6 Frontier Biotechnologies Competitive Strengths & Weaknesses
6.12 Shionogi
6.12.1 Shionogi Details
6.12.2 Shionogi Major Business
6.12.3 Shionogi HIV Antiretroviral Drug Product and Services
6.12.4 Shionogi HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Shionogi Recent Developments/Updates
6.12.6 Shionogi Competitive Strengths & Weaknesses
6.13 Julphar Bangladesh
6.13.1 Julphar Bangladesh Details
6.13.2 Julphar Bangladesh Major Business
6.13.3 Julphar Bangladesh HIV Antiretroviral Drug Product and Services
6.13.4 Julphar Bangladesh HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Julphar Bangladesh Recent Developments/Updates
6.13.6 Julphar Bangladesh Competitive Strengths & Weaknesses
6.14 Mylan Pharmaceuticals Inc.
6.14.1 Mylan Pharmaceuticals Inc. Details
6.14.2 Mylan Pharmaceuticals Inc. Major Business
6.14.3 Mylan Pharmaceuticals Inc. HIV Antiretroviral Drug Product and Services
6.14.4 Mylan Pharmaceuticals Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Mylan Pharmaceuticals Inc. Recent Developments/Updates
6.14.6 Mylan Pharmaceuticals Inc. Competitive Strengths & Weaknesses
6.15 Genentech, Inc.
6.15.1 Genentech, Inc. Details
6.15.2 Genentech, Inc. Major Business
6.15.3 Genentech, Inc. HIV Antiretroviral Drug Product and Services
6.15.4 Genentech, Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Genentech, Inc. Recent Developments/Updates
6.15.6 Genentech, Inc. Competitive Strengths & Weaknesses
6.16 Boehringer Ingelheim
6.16.1 Boehringer Ingelheim Details
6.16.2 Boehringer Ingelheim Major Business
6.16.3 Boehringer Ingelheim HIV Antiretroviral Drug Product and Services
6.16.4 Boehringer Ingelheim HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Boehringer Ingelheim Recent Developments/Updates
6.16.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
6.17 Cipla
6.17.1 Cipla Details
6.17.2 Cipla Major Business
6.17.3 Cipla HIV Antiretroviral Drug Product and Services
6.17.4 Cipla HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Cipla Recent Developments/Updates
6.17.6 Cipla Competitive Strengths & Weaknesses
6.18 MSD
6.18.1 MSD Details
6.18.2 MSD Major Business
6.18.3 MSD HIV Antiretroviral Drug Product and Services
6.18.4 MSD HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 MSD Recent Developments/Updates
6.18.6 MSD Competitive Strengths & Weaknesses
6.19 Abbott
6.19.1 Abbott Details
6.19.2 Abbott Major Business
6.19.3 Abbott HIV Antiretroviral Drug Product and Services
6.19.4 Abbott HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Abbott Recent Developments/Updates
6.19.6 Abbott Competitive Strengths & Weaknesses
6.20 Johnson & Johnson
6.20.1 Johnson & Johnson Details
6.20.2 Johnson & Johnson Major Business
6.20.3 Johnson & Johnson HIV Antiretroviral Drug Product and Services
6.20.4 Johnson & Johnson HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 Johnson & Johnson Recent Developments/Updates
6.20.6 Johnson & Johnson Competitive Strengths & Weaknesses
6.21 Biocon Limited
6.21.1 Biocon Limited Details
6.21.2 Biocon Limited Major Business
6.21.3 Biocon Limited HIV Antiretroviral Drug Product and Services
6.21.4 Biocon Limited HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.21.5 Biocon Limited Recent Developments/Updates
6.21.6 Biocon Limited Competitive Strengths & Weaknesses
6.22 Affine Formulations Limited
6.22.1 Affine Formulations Limited Details
6.22.2 Affine Formulations Limited Major Business
6.22.3 Affine Formulations Limited HIV Antiretroviral Drug Product and Services
6.22.4 Affine Formulations Limited HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.22.5 Affine Formulations Limited Recent Developments/Updates
6.22.6 Affine Formulations Limited Competitive Strengths & Weaknesses
6.23 IPCA Laboratories
6.23.1 IPCA Laboratories Details
6.23.2 IPCA Laboratories Major Business
6.23.3 IPCA Laboratories HIV Antiretroviral Drug Product and Services
6.23.4 IPCA Laboratories HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.23.5 IPCA Laboratories Recent Developments/Updates
6.23.6 IPCA Laboratories Competitive Strengths & Weaknesses
6.24 Natco Pharma
6.24.1 Natco Pharma Details
6.24.2 Natco Pharma Major Business
6.24.3 Natco Pharma HIV Antiretroviral Drug Product and Services
6.24.4 Natco Pharma HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.24.5 Natco Pharma Recent Developments/Updates
6.24.6 Natco Pharma Competitive Strengths & Weaknesses
6.25 Beacon Pharmaceuticals
6.25.1 Beacon Pharmaceuticals Details
6.25.2 Beacon Pharmaceuticals Major Business
6.25.3 Beacon Pharmaceuticals HIV Antiretroviral Drug Product and Services
6.25.4 Beacon Pharmaceuticals HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.25.5 Beacon Pharmaceuticals Recent Developments/Updates
6.25.6 Beacon Pharmaceuticals Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of HIV Antiretroviral Drug and Key Manufacturers
7.2 HIV Antiretroviral Drug Manufacturing Costs
7.3 HIV Antiretroviral Drug Production Process
7.4 HIV Antiretroviral Drug Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for HIV Antiretroviral Drug Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 HIV Antiretroviral Drug Typical Distributors
8.3 HIV Antiretroviral Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 HIV Antiretroviral Drug Introduction
1.2 World HIV Antiretroviral Drug Market Size & Forecast (2017 & 2021 & 2028)
1.3 World HIV Antiretroviral Drug Total Market by Region
1.3.1 World HIV Antiretroviral Drug Market Size by Region (2017-2028)
1.3.2 United States HIV Antiretroviral Drug Market Size (2017-2028)
1.3.3 China HIV Antiretroviral Drug Market Size (2017-2028)
1.3.4 Europe HIV Antiretroviral Drug Market Size (2017-2028)
1.3.5 Japan HIV Antiretroviral Drug Market Size (2017-2028)
1.3.6 South Korea HIV Antiretroviral Drug Market Size (2017-2028)
1.3.7 ASEAN HIV Antiretroviral Drug Market Size (2017-2028)
1.3.8 India HIV Antiretroviral Drug Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 HIV Antiretroviral Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 HIV Antiretroviral Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD HIV ANTIRETROVIRAL DRUG COMPANIES COMPETITIVE ANALYSIS
2.1 World HIV Antiretroviral Drug Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global HIV Antiretroviral Drug Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for HIV Antiretroviral Drug in 2021
2.2.3 Global Concentration Ratios (CR8) for HIV Antiretroviral Drug in 2021
2.3 HIV Antiretroviral Drug Company Evaluation Quadrant
2.4 HIV Antiretroviral Drug Market: Overall Company Footprint Analysis
2.4.1 HIV Antiretroviral Drug Market: Region Footprint
2.4.2 HIV Antiretroviral Drug Market: Company Product Type Footprint
2.4.3 HIV Antiretroviral Drug Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: HIV Antiretroviral Drug Market Comparison
3.1.1 United States VS China: HIV Antiretroviral Drug Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: HIV Antiretroviral Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States HIV Antiretroviral Drug Major Players and Market Share, 2017-2022
3.2.1 Major Players of HIV Antiretroviral Drug in United States, Headquarters (States, Country)
3.2.2 United States HIV Antiretroviral Drug Revenue by Domestic Player, (2017-2022)
3.3 China HIV Antiretroviral Drug Major Players and Market Share, 2017-2022
3.3.1 Major Players of HIV Antiretroviral Drug in China, Headquarters (Province, Country)
3.3.2 China HIV Antiretroviral Drug Revenue by Domestic Player, (2017-2022)
3.4 Rest of World HIV Antiretroviral Drug Major Players and Market Share, 2017-2022
3.4.1 Major Players of HIV Antiretroviral Drug in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World HIV Antiretroviral Drug Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World HIV Antiretroviral Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Nucleoside Reverse Transcriptase Inhibitors
4.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors
4.2.3 Protease Inhibitors
4.2.4 Fusion Inhibitors
4.2.5 Others
4.3 Market Segment by Type
4.3.1 World HIV Antiretroviral Drug Market Size by Type (2017-2022)
4.3.2 World HIV Antiretroviral Drug Market Size by Type (2023-2028)
4.3.3 World HIV Antiretroviral Drug Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World HIV Antiretroviral Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospital Pharmacies
5.2.2 Retail Pharmacies
5.2.3 Online Pharmacies
5.3 Market Segment by Application
5.3.1 World HIV Antiretroviral Drug Market Size by Application (2017-2022)
5.3.2 World HIV Antiretroviral Drug Market Size by Application (2023-2028)
5.3.3 World HIV Antiretroviral Drug Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 ViiV Healthcare(GlaxoSmithKline)
6.1.1 ViiV Healthcare(GlaxoSmithKline) Details
6.1.2 ViiV Healthcare(GlaxoSmithKline) Major Business
6.1.3 ViiV Healthcare(GlaxoSmithKline) HIV Antiretroviral Drug Product and Services
6.1.4 ViiV Healthcare(GlaxoSmithKline) HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 ViiV Healthcare(GlaxoSmithKline) Recent Developments/Updates
6.1.6 ViiV Healthcare(GlaxoSmithKline) Competitive Strengths & Weaknesses
6.2 Gilead Sciences
6.2.1 Gilead Sciences Details
6.2.2 Gilead Sciences Major Business
6.2.3 Gilead Sciences HIV Antiretroviral Drug Product and Services
6.2.4 Gilead Sciences HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Gilead Sciences Recent Developments/Updates
6.2.6 Gilead Sciences Competitive Strengths & Weaknesses
6.3 AbbVie Inc.
6.3.1 AbbVie Inc. Details
6.3.2 AbbVie Inc. Major Business
6.3.3 AbbVie Inc. HIV Antiretroviral Drug Product and Services
6.3.4 AbbVie Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 AbbVie Inc. Recent Developments/Updates
6.3.6 AbbVie Inc. Competitive Strengths & Weaknesses
6.4 Merck & Co
6.4.1 Merck & Co Details
6.4.2 Merck & Co Major Business
6.4.3 Merck & Co HIV Antiretroviral Drug Product and Services
6.4.4 Merck & Co HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Merck & Co Recent Developments/Updates
6.4.6 Merck & Co Competitive Strengths & Weaknesses
6.5 GSK
6.5.1 GSK Details
6.5.2 GSK Major Business
6.5.3 GSK HIV Antiretroviral Drug Product and Services
6.5.4 GSK HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 GSK Recent Developments/Updates
6.5.6 GSK Competitive Strengths & Weaknesses
6.6 Bristol-Myers Squibb Company
6.6.1 Bristol-Myers Squibb Company Details
6.6.2 Bristol-Myers Squibb Company Major Business
6.6.3 Bristol-Myers Squibb Company HIV Antiretroviral Drug Product and Services
6.6.4 Bristol-Myers Squibb Company HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.6.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
6.7 Theratechnologies Inc.
6.7.1 Theratechnologies Inc. Details
6.7.2 Theratechnologies Inc. Major Business
6.7.3 Theratechnologies Inc. HIV Antiretroviral Drug Product and Services
6.7.4 Theratechnologies Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Theratechnologies Inc. Recent Developments/Updates
6.7.6 Theratechnologies Inc. Competitive Strengths & Weaknesses
6.8 Roche Holding AG
6.8.1 Roche Holding AG Details
6.8.2 Roche Holding AG Major Business
6.8.3 Roche Holding AG HIV Antiretroviral Drug Product and Services
6.8.4 Roche Holding AG HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Roche Holding AG Recent Developments/Updates
6.8.6 Roche Holding AG Competitive Strengths & Weaknesses
6.9 Teva Pharmaceuticals
6.9.1 Teva Pharmaceuticals Details
6.9.2 Teva Pharmaceuticals Major Business
6.9.3 Teva Pharmaceuticals HIV Antiretroviral Drug Product and Services
6.9.4 Teva Pharmaceuticals HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Teva Pharmaceuticals Recent Developments/Updates
6.9.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
6.10 Pfizer
6.10.1 Pfizer Details
6.10.2 Pfizer Major Business
6.10.3 Pfizer HIV Antiretroviral Drug Product and Services
6.10.4 Pfizer HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Pfizer Recent Developments/Updates
6.10.6 Pfizer Competitive Strengths & Weaknesses
6.11 Frontier Biotechnologies
6.11.1 Frontier Biotechnologies Details
6.11.2 Frontier Biotechnologies Major Business
6.11.3 Frontier Biotechnologies HIV Antiretroviral Drug Product and Services
6.11.4 Frontier Biotechnologies HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Frontier Biotechnologies Recent Developments/Updates
6.11.6 Frontier Biotechnologies Competitive Strengths & Weaknesses
6.12 Shionogi
6.12.1 Shionogi Details
6.12.2 Shionogi Major Business
6.12.3 Shionogi HIV Antiretroviral Drug Product and Services
6.12.4 Shionogi HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Shionogi Recent Developments/Updates
6.12.6 Shionogi Competitive Strengths & Weaknesses
6.13 Julphar Bangladesh
6.13.1 Julphar Bangladesh Details
6.13.2 Julphar Bangladesh Major Business
6.13.3 Julphar Bangladesh HIV Antiretroviral Drug Product and Services
6.13.4 Julphar Bangladesh HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Julphar Bangladesh Recent Developments/Updates
6.13.6 Julphar Bangladesh Competitive Strengths & Weaknesses
6.14 Mylan Pharmaceuticals Inc.
6.14.1 Mylan Pharmaceuticals Inc. Details
6.14.2 Mylan Pharmaceuticals Inc. Major Business
6.14.3 Mylan Pharmaceuticals Inc. HIV Antiretroviral Drug Product and Services
6.14.4 Mylan Pharmaceuticals Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Mylan Pharmaceuticals Inc. Recent Developments/Updates
6.14.6 Mylan Pharmaceuticals Inc. Competitive Strengths & Weaknesses
6.15 Genentech, Inc.
6.15.1 Genentech, Inc. Details
6.15.2 Genentech, Inc. Major Business
6.15.3 Genentech, Inc. HIV Antiretroviral Drug Product and Services
6.15.4 Genentech, Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Genentech, Inc. Recent Developments/Updates
6.15.6 Genentech, Inc. Competitive Strengths & Weaknesses
6.16 Boehringer Ingelheim
6.16.1 Boehringer Ingelheim Details
6.16.2 Boehringer Ingelheim Major Business
6.16.3 Boehringer Ingelheim HIV Antiretroviral Drug Product and Services
6.16.4 Boehringer Ingelheim HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Boehringer Ingelheim Recent Developments/Updates
6.16.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
6.17 Cipla
6.17.1 Cipla Details
6.17.2 Cipla Major Business
6.17.3 Cipla HIV Antiretroviral Drug Product and Services
6.17.4 Cipla HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Cipla Recent Developments/Updates
6.17.6 Cipla Competitive Strengths & Weaknesses
6.18 MSD
6.18.1 MSD Details
6.18.2 MSD Major Business
6.18.3 MSD HIV Antiretroviral Drug Product and Services
6.18.4 MSD HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 MSD Recent Developments/Updates
6.18.6 MSD Competitive Strengths & Weaknesses
6.19 Abbott
6.19.1 Abbott Details
6.19.2 Abbott Major Business
6.19.3 Abbott HIV Antiretroviral Drug Product and Services
6.19.4 Abbott HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Abbott Recent Developments/Updates
6.19.6 Abbott Competitive Strengths & Weaknesses
6.20 Johnson & Johnson
6.20.1 Johnson & Johnson Details
6.20.2 Johnson & Johnson Major Business
6.20.3 Johnson & Johnson HIV Antiretroviral Drug Product and Services
6.20.4 Johnson & Johnson HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 Johnson & Johnson Recent Developments/Updates
6.20.6 Johnson & Johnson Competitive Strengths & Weaknesses
6.21 Biocon Limited
6.21.1 Biocon Limited Details
6.21.2 Biocon Limited Major Business
6.21.3 Biocon Limited HIV Antiretroviral Drug Product and Services
6.21.4 Biocon Limited HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.21.5 Biocon Limited Recent Developments/Updates
6.21.6 Biocon Limited Competitive Strengths & Weaknesses
6.22 Affine Formulations Limited
6.22.1 Affine Formulations Limited Details
6.22.2 Affine Formulations Limited Major Business
6.22.3 Affine Formulations Limited HIV Antiretroviral Drug Product and Services
6.22.4 Affine Formulations Limited HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.22.5 Affine Formulations Limited Recent Developments/Updates
6.22.6 Affine Formulations Limited Competitive Strengths & Weaknesses
6.23 IPCA Laboratories
6.23.1 IPCA Laboratories Details
6.23.2 IPCA Laboratories Major Business
6.23.3 IPCA Laboratories HIV Antiretroviral Drug Product and Services
6.23.4 IPCA Laboratories HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.23.5 IPCA Laboratories Recent Developments/Updates
6.23.6 IPCA Laboratories Competitive Strengths & Weaknesses
6.24 Natco Pharma
6.24.1 Natco Pharma Details
6.24.2 Natco Pharma Major Business
6.24.3 Natco Pharma HIV Antiretroviral Drug Product and Services
6.24.4 Natco Pharma HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.24.5 Natco Pharma Recent Developments/Updates
6.24.6 Natco Pharma Competitive Strengths & Weaknesses
6.25 Beacon Pharmaceuticals
6.25.1 Beacon Pharmaceuticals Details
6.25.2 Beacon Pharmaceuticals Major Business
6.25.3 Beacon Pharmaceuticals HIV Antiretroviral Drug Product and Services
6.25.4 Beacon Pharmaceuticals HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022)
6.25.5 Beacon Pharmaceuticals Recent Developments/Updates
6.25.6 Beacon Pharmaceuticals Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of HIV Antiretroviral Drug and Key Manufacturers
7.2 HIV Antiretroviral Drug Manufacturing Costs
7.3 HIV Antiretroviral Drug Production Process
7.4 HIV Antiretroviral Drug Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for HIV Antiretroviral Drug Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 HIV Antiretroviral Drug Typical Distributors
8.3 HIV Antiretroviral Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World HIV Antiretroviral Drug Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World HIV Antiretroviral Drug Market Size by Region (2017-2022) & (USD Million)
Table 3. World HIV Antiretroviral Drug Market Size by Region (2023-2028) & (USD Million)
Table 4. World HIV Antiretroviral Drug Market Size Market Share by Region (2017-2022)
Table 5. World HIV Antiretroviral Drug Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World HIV Antiretroviral Drug Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key HIV Antiretroviral Drug Players in 2021
Table 9. World HIV Antiretroviral Drug Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global HIV Antiretroviral Drug Company Evaluation Quadrant
Table 11. Head Office of Key HIV Antiretroviral Drug Player
Table 12. HIV Antiretroviral Drug Market: Company Product Type Footprint
Table 13. HIV Antiretroviral Drug Market: Company Product Application Footprint
Table 14. HIV Antiretroviral Drug Mergers & Acquisitions Activity
Table 15. United States VS China HIV Antiretroviral Drug Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of HIV Antiretroviral Drug in United States, Headquarters (States, Country)
Table 17. United States HIV Antiretroviral Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States HIV Antiretroviral Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of HIV Antiretroviral Drug in China, Company Headquarters (Province, Country)
Table 20. China HIV Antiretroviral Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China HIV Antiretroviral Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of HIV Antiretroviral Drug in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World HIV Antiretroviral Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World HIV Antiretroviral Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World HIV Antiretroviral Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World HIV Antiretroviral Drug Revenue by Type (2017-2022) & (USD Million)
Table 27. World HIV Antiretroviral Drug Revenue by Type (2023-2028) & (USD Million)
Table 28. World HIV Antiretroviral Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World HIV Antiretroviral Drug Revenue by Application (2017-2022) & (USD Million)
Table 30. World HIV Antiretroviral Drug Revenue by Application (2023-2028) & (USD Million)
Table 31. ViiV Healthcare(GlaxoSmithKline) Basic Information, Area Served and Competitors
Table 32. ViiV Healthcare(GlaxoSmithKline) Major Business
Table 33. ViiV Healthcare(GlaxoSmithKline) HIV Antiretroviral Drug Product and Services
Table 34. ViiV Healthcare(GlaxoSmithKline) HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. ViiV Healthcare(GlaxoSmithKline) Recent Developments/Updates
Table 36. ViiV Healthcare(GlaxoSmithKline) Competitive Strengths & Weaknesses
Table 37. Gilead Sciences Basic Information, Area Served and Competitors
Table 38. Gilead Sciences Major Business
Table 39. Gilead Sciences HIV Antiretroviral Drug Product and Services
Table 40. Gilead Sciences HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Gilead Sciences Recent Developments/Updates
Table 42. Gilead Sciences Competitive Strengths & Weaknesses
Table 43. AbbVie Inc. Basic Information, Area Served and Competitors
Table 44. AbbVie Inc. Major Business
Table 45. AbbVie Inc. HIV Antiretroviral Drug Product and Services
Table 46. AbbVie Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. AbbVie Inc. Recent Developments/Updates
Table 48. AbbVie Inc. Competitive Strengths & Weaknesses
Table 49. Merck & Co Basic Information, Area Served and Competitors
Table 50. Merck & Co Major Business
Table 51. Merck & Co HIV Antiretroviral Drug Product and Services
Table 52. Merck & Co HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Merck & Co Recent Developments/Updates
Table 54. Merck & Co Competitive Strengths & Weaknesses
Table 55. GSK Basic Information, Area Served and Competitors
Table 56. GSK Major Business
Table 57. GSK HIV Antiretroviral Drug Product and Services
Table 58. GSK HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. GSK Recent Developments/Updates
Table 60. GSK Competitive Strengths & Weaknesses
Table 61. Bristol-Myers Squibb Company Basic Information, Area Served and Competitors
Table 62. Bristol-Myers Squibb Company Major Business
Table 63. Bristol-Myers Squibb Company HIV Antiretroviral Drug Product and Services
Table 64. Bristol-Myers Squibb Company HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Bristol-Myers Squibb Company Recent Developments/Updates
Table 66. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 67. Theratechnologies Inc. Basic Information, Area Served and Competitors
Table 68. Theratechnologies Inc. Major Business
Table 69. Theratechnologies Inc. HIV Antiretroviral Drug Product and Services
Table 70. Theratechnologies Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Theratechnologies Inc. Recent Developments/Updates
Table 72. Theratechnologies Inc. Competitive Strengths & Weaknesses
Table 73. Roche Holding AG Basic Information, Area Served and Competitors
Table 74. Roche Holding AG Major Business
Table 75. Roche Holding AG HIV Antiretroviral Drug Product and Services
Table 76. Roche Holding AG HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Roche Holding AG Recent Developments/Updates
Table 78. Roche Holding AG Competitive Strengths & Weaknesses
Table 79. Teva Pharmaceuticals Basic Information, Area Served and Competitors
Table 80. Teva Pharmaceuticals Major Business
Table 81. Teva Pharmaceuticals HIV Antiretroviral Drug Product and Services
Table 82. Teva Pharmaceuticals HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Teva Pharmaceuticals Recent Developments/Updates
Table 84. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Pfizer Basic Information, Area Served and Competitors
Table 86. Pfizer Major Business
Table 87. Pfizer HIV Antiretroviral Drug Product and Services
Table 88. Pfizer HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Pfizer Recent Developments/Updates
Table 90. Pfizer Competitive Strengths & Weaknesses
Table 91. Frontier Biotechnologies Basic Information, Area Served and Competitors
Table 92. Frontier Biotechnologies Major Business
Table 93. Frontier Biotechnologies HIV Antiretroviral Drug Product and Services
Table 94. Frontier Biotechnologies HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Frontier Biotechnologies Recent Developments/Updates
Table 96. Frontier Biotechnologies Competitive Strengths & Weaknesses
Table 97. Shionogi Basic Information, Area Served and Competitors
Table 98. Shionogi Major Business
Table 99. Shionogi HIV Antiretroviral Drug Product and Services
Table 100. Shionogi HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Shionogi Recent Developments/Updates
Table 102. Shionogi Competitive Strengths & Weaknesses
Table 103. Julphar Bangladesh Basic Information, Area Served and Competitors
Table 104. Julphar Bangladesh Major Business
Table 105. Julphar Bangladesh HIV Antiretroviral Drug Product and Services
Table 106. Julphar Bangladesh HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Julphar Bangladesh Recent Developments/Updates
Table 108. Julphar Bangladesh Competitive Strengths & Weaknesses
Table 109. Mylan Pharmaceuticals Inc. Basic Information, Area Served and Competitors
Table 110. Mylan Pharmaceuticals Inc. Major Business
Table 111. Mylan Pharmaceuticals Inc. HIV Antiretroviral Drug Product and Services
Table 112. Mylan Pharmaceuticals Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Mylan Pharmaceuticals Inc. Recent Developments/Updates
Table 114. Mylan Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 115. Genentech, Inc. Basic Information, Area Served and Competitors
Table 116. Genentech, Inc. Major Business
Table 117. Genentech, Inc. HIV Antiretroviral Drug Product and Services
Table 118. Genentech, Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Genentech, Inc. Recent Developments/Updates
Table 120. Genentech, Inc. Competitive Strengths & Weaknesses
Table 121. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 122. Boehringer Ingelheim Major Business
Table 123. Boehringer Ingelheim HIV Antiretroviral Drug Product and Services
Table 124. Boehringer Ingelheim HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Boehringer Ingelheim Recent Developments/Updates
Table 126. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 127. Cipla Basic Information, Area Served and Competitors
Table 128. Cipla Major Business
Table 129. Cipla HIV Antiretroviral Drug Product and Services
Table 130. Cipla HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Cipla Recent Developments/Updates
Table 132. Cipla Competitive Strengths & Weaknesses
Table 133. MSD Basic Information, Area Served and Competitors
Table 134. MSD Major Business
Table 135. MSD HIV Antiretroviral Drug Product and Services
Table 136. MSD HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. MSD Recent Developments/Updates
Table 138. MSD Competitive Strengths & Weaknesses
Table 139. Abbott Basic Information, Area Served and Competitors
Table 140. Abbott Major Business
Table 141. Abbott HIV Antiretroviral Drug Product and Services
Table 142. Abbott HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Abbott Recent Developments/Updates
Table 144. Abbott Competitive Strengths & Weaknesses
Table 145. Johnson & Johnson Basic Information, Area Served and Competitors
Table 146. Johnson & Johnson Major Business
Table 147. Johnson & Johnson HIV Antiretroviral Drug Product and Services
Table 148. Johnson & Johnson HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. Johnson & Johnson Recent Developments/Updates
Table 150. Johnson & Johnson Competitive Strengths & Weaknesses
Table 151. Biocon Limited Basic Information, Area Served and Competitors
Table 152. Biocon Limited Major Business
Table 153. Biocon Limited HIV Antiretroviral Drug Product and Services
Table 154. Biocon Limited HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 155. Biocon Limited Recent Developments/Updates
Table 156. Biocon Limited Competitive Strengths & Weaknesses
Table 157. Affine Formulations Limited Basic Information, Area Served and Competitors
Table 158. Affine Formulations Limited Major Business
Table 159. Affine Formulations Limited HIV Antiretroviral Drug Product and Services
Table 160. Affine Formulations Limited HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 161. Affine Formulations Limited Recent Developments/Updates
Table 162. Affine Formulations Limited Competitive Strengths & Weaknesses
Table 163. IPCA Laboratories Basic Information, Area Served and Competitors
Table 164. IPCA Laboratories Major Business
Table 165. IPCA Laboratories HIV Antiretroviral Drug Product and Services
Table 166. IPCA Laboratories HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 167. IPCA Laboratories Recent Developments/Updates
Table 168. IPCA Laboratories Competitive Strengths & Weaknesses
Table 169. Natco Pharma Basic Information, Area Served and Competitors
Table 170. Natco Pharma Major Business
Table 171. Natco Pharma HIV Antiretroviral Drug Product and Services
Table 172. Natco Pharma HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 173. Natco Pharma Recent Developments/Updates
Table 174. Beacon Pharmaceuticals Basic Information, Area Served and Competitors
Table 175. Beacon Pharmaceuticals Major Business
Table 176. Beacon Pharmaceuticals HIV Antiretroviral Drug Product and Services
Table 177. Beacon Pharmaceuticals HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 178. HIV Antiretroviral Drug Raw Material
Table 179. Key Manufacturers of HIV Antiretroviral Drug Raw Materials
Table 180. HIV Antiretroviral Drug Typical Distributors
Table 181. HIV Antiretroviral Drug Typical Customers
Table 1. World HIV Antiretroviral Drug Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World HIV Antiretroviral Drug Market Size by Region (2017-2022) & (USD Million)
Table 3. World HIV Antiretroviral Drug Market Size by Region (2023-2028) & (USD Million)
Table 4. World HIV Antiretroviral Drug Market Size Market Share by Region (2017-2022)
Table 5. World HIV Antiretroviral Drug Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World HIV Antiretroviral Drug Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key HIV Antiretroviral Drug Players in 2021
Table 9. World HIV Antiretroviral Drug Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global HIV Antiretroviral Drug Company Evaluation Quadrant
Table 11. Head Office of Key HIV Antiretroviral Drug Player
Table 12. HIV Antiretroviral Drug Market: Company Product Type Footprint
Table 13. HIV Antiretroviral Drug Market: Company Product Application Footprint
Table 14. HIV Antiretroviral Drug Mergers & Acquisitions Activity
Table 15. United States VS China HIV Antiretroviral Drug Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of HIV Antiretroviral Drug in United States, Headquarters (States, Country)
Table 17. United States HIV Antiretroviral Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States HIV Antiretroviral Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of HIV Antiretroviral Drug in China, Company Headquarters (Province, Country)
Table 20. China HIV Antiretroviral Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China HIV Antiretroviral Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of HIV Antiretroviral Drug in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World HIV Antiretroviral Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World HIV Antiretroviral Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World HIV Antiretroviral Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World HIV Antiretroviral Drug Revenue by Type (2017-2022) & (USD Million)
Table 27. World HIV Antiretroviral Drug Revenue by Type (2023-2028) & (USD Million)
Table 28. World HIV Antiretroviral Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World HIV Antiretroviral Drug Revenue by Application (2017-2022) & (USD Million)
Table 30. World HIV Antiretroviral Drug Revenue by Application (2023-2028) & (USD Million)
Table 31. ViiV Healthcare(GlaxoSmithKline) Basic Information, Area Served and Competitors
Table 32. ViiV Healthcare(GlaxoSmithKline) Major Business
Table 33. ViiV Healthcare(GlaxoSmithKline) HIV Antiretroviral Drug Product and Services
Table 34. ViiV Healthcare(GlaxoSmithKline) HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. ViiV Healthcare(GlaxoSmithKline) Recent Developments/Updates
Table 36. ViiV Healthcare(GlaxoSmithKline) Competitive Strengths & Weaknesses
Table 37. Gilead Sciences Basic Information, Area Served and Competitors
Table 38. Gilead Sciences Major Business
Table 39. Gilead Sciences HIV Antiretroviral Drug Product and Services
Table 40. Gilead Sciences HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Gilead Sciences Recent Developments/Updates
Table 42. Gilead Sciences Competitive Strengths & Weaknesses
Table 43. AbbVie Inc. Basic Information, Area Served and Competitors
Table 44. AbbVie Inc. Major Business
Table 45. AbbVie Inc. HIV Antiretroviral Drug Product and Services
Table 46. AbbVie Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. AbbVie Inc. Recent Developments/Updates
Table 48. AbbVie Inc. Competitive Strengths & Weaknesses
Table 49. Merck & Co Basic Information, Area Served and Competitors
Table 50. Merck & Co Major Business
Table 51. Merck & Co HIV Antiretroviral Drug Product and Services
Table 52. Merck & Co HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Merck & Co Recent Developments/Updates
Table 54. Merck & Co Competitive Strengths & Weaknesses
Table 55. GSK Basic Information, Area Served and Competitors
Table 56. GSK Major Business
Table 57. GSK HIV Antiretroviral Drug Product and Services
Table 58. GSK HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. GSK Recent Developments/Updates
Table 60. GSK Competitive Strengths & Weaknesses
Table 61. Bristol-Myers Squibb Company Basic Information, Area Served and Competitors
Table 62. Bristol-Myers Squibb Company Major Business
Table 63. Bristol-Myers Squibb Company HIV Antiretroviral Drug Product and Services
Table 64. Bristol-Myers Squibb Company HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Bristol-Myers Squibb Company Recent Developments/Updates
Table 66. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 67. Theratechnologies Inc. Basic Information, Area Served and Competitors
Table 68. Theratechnologies Inc. Major Business
Table 69. Theratechnologies Inc. HIV Antiretroviral Drug Product and Services
Table 70. Theratechnologies Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Theratechnologies Inc. Recent Developments/Updates
Table 72. Theratechnologies Inc. Competitive Strengths & Weaknesses
Table 73. Roche Holding AG Basic Information, Area Served and Competitors
Table 74. Roche Holding AG Major Business
Table 75. Roche Holding AG HIV Antiretroviral Drug Product and Services
Table 76. Roche Holding AG HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Roche Holding AG Recent Developments/Updates
Table 78. Roche Holding AG Competitive Strengths & Weaknesses
Table 79. Teva Pharmaceuticals Basic Information, Area Served and Competitors
Table 80. Teva Pharmaceuticals Major Business
Table 81. Teva Pharmaceuticals HIV Antiretroviral Drug Product and Services
Table 82. Teva Pharmaceuticals HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Teva Pharmaceuticals Recent Developments/Updates
Table 84. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Pfizer Basic Information, Area Served and Competitors
Table 86. Pfizer Major Business
Table 87. Pfizer HIV Antiretroviral Drug Product and Services
Table 88. Pfizer HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Pfizer Recent Developments/Updates
Table 90. Pfizer Competitive Strengths & Weaknesses
Table 91. Frontier Biotechnologies Basic Information, Area Served and Competitors
Table 92. Frontier Biotechnologies Major Business
Table 93. Frontier Biotechnologies HIV Antiretroviral Drug Product and Services
Table 94. Frontier Biotechnologies HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Frontier Biotechnologies Recent Developments/Updates
Table 96. Frontier Biotechnologies Competitive Strengths & Weaknesses
Table 97. Shionogi Basic Information, Area Served and Competitors
Table 98. Shionogi Major Business
Table 99. Shionogi HIV Antiretroviral Drug Product and Services
Table 100. Shionogi HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Shionogi Recent Developments/Updates
Table 102. Shionogi Competitive Strengths & Weaknesses
Table 103. Julphar Bangladesh Basic Information, Area Served and Competitors
Table 104. Julphar Bangladesh Major Business
Table 105. Julphar Bangladesh HIV Antiretroviral Drug Product and Services
Table 106. Julphar Bangladesh HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Julphar Bangladesh Recent Developments/Updates
Table 108. Julphar Bangladesh Competitive Strengths & Weaknesses
Table 109. Mylan Pharmaceuticals Inc. Basic Information, Area Served and Competitors
Table 110. Mylan Pharmaceuticals Inc. Major Business
Table 111. Mylan Pharmaceuticals Inc. HIV Antiretroviral Drug Product and Services
Table 112. Mylan Pharmaceuticals Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Mylan Pharmaceuticals Inc. Recent Developments/Updates
Table 114. Mylan Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 115. Genentech, Inc. Basic Information, Area Served and Competitors
Table 116. Genentech, Inc. Major Business
Table 117. Genentech, Inc. HIV Antiretroviral Drug Product and Services
Table 118. Genentech, Inc. HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Genentech, Inc. Recent Developments/Updates
Table 120. Genentech, Inc. Competitive Strengths & Weaknesses
Table 121. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 122. Boehringer Ingelheim Major Business
Table 123. Boehringer Ingelheim HIV Antiretroviral Drug Product and Services
Table 124. Boehringer Ingelheim HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Boehringer Ingelheim Recent Developments/Updates
Table 126. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 127. Cipla Basic Information, Area Served and Competitors
Table 128. Cipla Major Business
Table 129. Cipla HIV Antiretroviral Drug Product and Services
Table 130. Cipla HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Cipla Recent Developments/Updates
Table 132. Cipla Competitive Strengths & Weaknesses
Table 133. MSD Basic Information, Area Served and Competitors
Table 134. MSD Major Business
Table 135. MSD HIV Antiretroviral Drug Product and Services
Table 136. MSD HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. MSD Recent Developments/Updates
Table 138. MSD Competitive Strengths & Weaknesses
Table 139. Abbott Basic Information, Area Served and Competitors
Table 140. Abbott Major Business
Table 141. Abbott HIV Antiretroviral Drug Product and Services
Table 142. Abbott HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Abbott Recent Developments/Updates
Table 144. Abbott Competitive Strengths & Weaknesses
Table 145. Johnson & Johnson Basic Information, Area Served and Competitors
Table 146. Johnson & Johnson Major Business
Table 147. Johnson & Johnson HIV Antiretroviral Drug Product and Services
Table 148. Johnson & Johnson HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. Johnson & Johnson Recent Developments/Updates
Table 150. Johnson & Johnson Competitive Strengths & Weaknesses
Table 151. Biocon Limited Basic Information, Area Served and Competitors
Table 152. Biocon Limited Major Business
Table 153. Biocon Limited HIV Antiretroviral Drug Product and Services
Table 154. Biocon Limited HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 155. Biocon Limited Recent Developments/Updates
Table 156. Biocon Limited Competitive Strengths & Weaknesses
Table 157. Affine Formulations Limited Basic Information, Area Served and Competitors
Table 158. Affine Formulations Limited Major Business
Table 159. Affine Formulations Limited HIV Antiretroviral Drug Product and Services
Table 160. Affine Formulations Limited HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 161. Affine Formulations Limited Recent Developments/Updates
Table 162. Affine Formulations Limited Competitive Strengths & Weaknesses
Table 163. IPCA Laboratories Basic Information, Area Served and Competitors
Table 164. IPCA Laboratories Major Business
Table 165. IPCA Laboratories HIV Antiretroviral Drug Product and Services
Table 166. IPCA Laboratories HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 167. IPCA Laboratories Recent Developments/Updates
Table 168. IPCA Laboratories Competitive Strengths & Weaknesses
Table 169. Natco Pharma Basic Information, Area Served and Competitors
Table 170. Natco Pharma Major Business
Table 171. Natco Pharma HIV Antiretroviral Drug Product and Services
Table 172. Natco Pharma HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 173. Natco Pharma Recent Developments/Updates
Table 174. Beacon Pharmaceuticals Basic Information, Area Served and Competitors
Table 175. Beacon Pharmaceuticals Major Business
Table 176. Beacon Pharmaceuticals HIV Antiretroviral Drug Product and Services
Table 177. Beacon Pharmaceuticals HIV Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 178. HIV Antiretroviral Drug Raw Material
Table 179. Key Manufacturers of HIV Antiretroviral Drug Raw Materials
Table 180. HIV Antiretroviral Drug Typical Distributors
Table 181. HIV Antiretroviral Drug Typical Customers
LIST OF FIGURES
Figure 1. HIV Antiretroviral Drug Picture
Figure 2. World HIV Antiretroviral Drug Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World HIV Antiretroviral Drug Total Market Size (2017-2028) & (USD Million)
Figure 4. World HIV Antiretroviral Drug Market Size Market Share by Region (2017-2028)
Figure 5. United States HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 6. China HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 7. Europe HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 8. Japan HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 9. South Korea HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 11. India HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 12. HIV Antiretroviral Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of HIV Antiretroviral Drug by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for HIV Antiretroviral Drug Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for HIV Antiretroviral Drug Markets in 2021
Figure 17. United States VS China: HIV Antiretroviral Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World HIV Antiretroviral Drug Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World HIV Antiretroviral Drug Market Size Market Share by Type in 2021
Figure 20. Nucleoside Reverse Transcriptase Inhibitors
Figure 21. Non-Nucleoside Reverse Transcriptase Inhibitors
Figure 22. Protease Inhibitors
Figure 23. Fusion Inhibitors
Figure 24. Others
Figure 25. World HIV Antiretroviral Drug Market Size Market Share by Type (2017-2028)
Figure 26. World HIV Antiretroviral Drug Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 27. World HIV Antiretroviral Drug Market Size Market Share by Application in 2021
Figure 28. Hospital Pharmacies
Figure 29. Retail Pharmacies
Figure 30. Online Pharmacies
Figure 31. World HIV Antiretroviral Drug Market Size Market Share by Application (2017-2028)
Figure 32. Manufacturing Cost Structure Analysis of HIV Antiretroviral Drug in 2021
Figure 33. Manufacturing Process Analysis of HIV Antiretroviral Drug
Figure 34. HIV Antiretroviral Drug Industrial Chain
Figure 35. Distribution Channel Breakdown for HIV Antiretroviral Drug Shipments (%): 2017-2028
Figure 36. Direct Channel Pros & Cons
Figure 37. Indirect Channel Pros & Cons
Figure 38. Methodology
Figure 39. Research Process and Data Source
Figure 1. HIV Antiretroviral Drug Picture
Figure 2. World HIV Antiretroviral Drug Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World HIV Antiretroviral Drug Total Market Size (2017-2028) & (USD Million)
Figure 4. World HIV Antiretroviral Drug Market Size Market Share by Region (2017-2028)
Figure 5. United States HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 6. China HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 7. Europe HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 8. Japan HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 9. South Korea HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 11. India HIV Antiretroviral Drug Market Size (2017-2028) & (USD Million)
Figure 12. HIV Antiretroviral Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of HIV Antiretroviral Drug by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for HIV Antiretroviral Drug Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for HIV Antiretroviral Drug Markets in 2021
Figure 17. United States VS China: HIV Antiretroviral Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World HIV Antiretroviral Drug Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World HIV Antiretroviral Drug Market Size Market Share by Type in 2021
Figure 20. Nucleoside Reverse Transcriptase Inhibitors
Figure 21. Non-Nucleoside Reverse Transcriptase Inhibitors
Figure 22. Protease Inhibitors
Figure 23. Fusion Inhibitors
Figure 24. Others
Figure 25. World HIV Antiretroviral Drug Market Size Market Share by Type (2017-2028)
Figure 26. World HIV Antiretroviral Drug Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 27. World HIV Antiretroviral Drug Market Size Market Share by Application in 2021
Figure 28. Hospital Pharmacies
Figure 29. Retail Pharmacies
Figure 30. Online Pharmacies
Figure 31. World HIV Antiretroviral Drug Market Size Market Share by Application (2017-2028)
Figure 32. Manufacturing Cost Structure Analysis of HIV Antiretroviral Drug in 2021
Figure 33. Manufacturing Process Analysis of HIV Antiretroviral Drug
Figure 34. HIV Antiretroviral Drug Industrial Chain
Figure 35. Distribution Channel Breakdown for HIV Antiretroviral Drug Shipments (%): 2017-2028
Figure 36. Direct Channel Pros & Cons
Figure 37. Indirect Channel Pros & Cons
Figure 38. Methodology
Figure 39. Research Process and Data Source
